The a2 Milk Company Limited (ACOPY)
ValueMarkers Composite Index
15% above intrinsic value ($5)
The a2 Milk Company Limited (ACOPY) — VMCI valuation read
The a2 Milk Company Limited sits at VMCI 59/100, with the Consumer Defensive sector median at 50. That 9-point spread is the first thing to note on ACOPY: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.
Form 4 disclosures on ACOPY are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.
**Investor frame.** The Value read on ACOPY: ACOPY trades at 14.0x earnings, 22% below the Consumer Defensive median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Consumer Defensive median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -0.7x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.
ACOPY rose 0.8% over the trailing 7 days, with a -13.4% read on a 30-day basis.
The a2 Milk Company Limited, together with its subsidiaries, sells A2 protein type branded milk and related products in Australia, New Zealand, China, other Asian countries, and the United States. The company offers fresh milk under the a2 Milk brand; and infant formula under the a2 Platinum brand. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand.
Related Stocks in Consumer Defensive
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.